| Primary information |
|---|
| ID | 16278 |
| Uniprot ID | B6DT16 |
| Description | Secretogranin-1 (Chromogranin-B) (CgB) (Glucagonoma peptide) (Secretogranin-I) (SgI) [Cleaved into- PE-11; CCB peptide short form; CCB peptide long form] |
| Organism | Rhodnius prolixus |
| Txonomy | Rattus ; Murinae ; Muridae ; Muroidea ; Myomorpha ; Rodentia ; Glires ; Euarchontoglires ; Boreoeutheria ; Eutheria ; Theria ; Mammalia ; Amniota ; Tetrapoda ; Dipnotetrapodomorpha ; Sarcopterygii ; Euteleostomi ; Teleostomi ; Gnathostomata ; Vertebrata ; Craniata ; Chordata ; Deuterostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
| Subcellular Location | secreted |
| Developmental Stage | First expressed in the brain around embryonic days 13-14; and peaks by postnatal day 20. |
| Similarity | Orcokinin family |
| Tissue Specificity | Expressed in the brain; adrenal medulla and anterior pituitary. In the brain; localized to the hippocampal formation; the endocrine hypothalamus; the olfactory system; and in anatomically distinct str |
| Post Translational Modification | NA |
| Function | Myotropic |
| Length | 675 |
| Molecular Weight | 77 |
| Name | Orcokinin-2 |
| Sequence | NFDEIDRSGFDGFV |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|